Educational Program sponsored by Recordati Rare Diseases – July 22nd
You are invited to an educational program sponsored by Recordati Rare Diseases SYLVANT®: The first & only FDA-approved therapy for your patients with Idiopathic Multicentric Castleman Disease (iMCD)
Presented by: Corey Caser, MD
CEO, Access for Advanced Health Institute Clinical Professor, University of Washington
Date and Time: Monday, July 22, 2024, 6:00 – 8:30pm (PDT)
Location: Carpe Diem Restaurant, 1001 2nd St. Suite #185, Napa, CA 94559
To attend, please contact: Sheila Babby at sheila.babby@recordati.com or 925-719-1002